OBR Trade Journal LOGO
Don't wait for approval… subscribe today to Oncology Business Review.
Oncology Business Review is a primary information resource dedicated to the business of the oncology industry. We utilize a journalistic style, perspectives from multiple oncology stakeholders, exclusive data, and our expertise in the field to develop provocative content for people who work in and honestly care about the commercial oncology industry.
Our primary audiences include oncologists, practice managers, oncology pharmacists, payer medical directors, cancer center administrators, and all company departments including medical affairs, finance, marketing, legal, regulatory, sales force, reimbursement, and all the supportive agencies serving the pharmaceutical industry such as marketing agencies, reimbursement vendors, and CROs.
We provide at least 4 feature articles in each issue of OBR, 6 issues per year. Each issue is carefully fabricated developed to balance scientific and business topics and information reaching a diverse oncology audience.
Areas of concentration in each issue can include: Practice Management, Pipeline Perspectives, Symposium Proceedings, Marketing, Legal & Regulatory, Applied Science, Market Research and Financial Analysis. We also feature recurring elements such as Tumor Ticker, OBR Crossword, On-Currences, News Flashes which help make up a comprehensive analysis of recent oncology news and events.
Heard enough? You can sample some our content by clicking on the links to the left or by visiting the OBR archives. If you like what you see, don’t wait for approval, subscribe to OBR by clicking below.
